Sec Form 13G Filing - 3I CORP filing for IQVIA HOLDINGS INC (IQV) - 2016-06-16

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Schedule 13G

Under the Securities Exchange Act of 1934

(Amendment No. 3)

 

 

Quintiles Transnational Holdings Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

74876Y101

(CUSIP Number)

June 13, 2016

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 74876Y101   13G   Page  2  of 8 Pages

 

 

  1   

NAMES OF REPORTING PERSONS

 

3i Corporation

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  x        (b)  ¨

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Massachusetts

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

      5     

SOLE VOTING POWER:

 

0

      6     

SHARED VOTING POWER:

 

3,958,501

      7     

SOLE DISPOSITIVE POWER:

 

0

      8     

SHARED DISPOSITIVE POWER:

 

3,958,501

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

3,958,501

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

3.3%

12  

TYPE OF REPORTING PERSON*

 

CO


CUSIP No. 74876Y101   13G   Page  3  of 8 Pages

 

 

  1   

NAMES OF REPORTING PERSONS

 

3i U.S. Growth Corporation

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  x        (b)  ¨

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

      5     

SOLE VOTING POWER:

 

0

      6     

SHARED VOTING POWER:

 

3,958,501

      7     

SOLE DISPOSITIVE POWER:

 

0

      8     

SHARED DISPOSITIVE POWER:

 

3,958,501

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

3,958,501

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

3.3%

12  

TYPE OF REPORTING PERSON*

 

CO


CUSIP No. 74876Y101   13G   Page  4  of 8 Pages

 

Item 1(a) Name of Issuer:

Quintiles Transnational Holdings Inc.

 

Item 1(b) Address of Issuer’s Principal Executive Offices:

4820 Emperor Blvd.

Durham, North Carolina 27703

 

Item 2(a) Name of Person Filing:

This Schedule 13G is being jointly filed by each of the following persons (together, the “Reporting Persons”) pursuant to Rule 13-d(1)(k) promulgated by the Securities and Exchange Commission pursuant to Section 13 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”):

 

   

3i Corporation

 

   

3i U.S. Growth Corporation

The Reporting Persons have entered into a Joint Filing Agreement, dated the date hereof, a copy of which is filed with this Schedule 13G as Exhibit A attached hereto, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Exchange Act.

 

Item 2(b) Address of Principal Business Office or, if none, Residence:

The address of the principal business office of each of the Reporting Persons is One Grand Central Place, 60 E. 42nd Street, Suite 4100 (@Vanderbilt), New York, New York 10165.

 

Item 2(c) Citizenship:

 

   

3i Corporation: Massachusetts corporation

 

   

3i U.S. Growth Corporation: Delaware corporation

 

Item 2(d) Title of Class of Securities:

Common Stock, par value $0.01 per share.

 

Item 2(e) CUSIP Number.:

74876Y101

 

Item 3 If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a:

Not applicable


CUSIP No. 74876Y101   13G   Page  5  of 8 Pages

 

 

Item 4 Ownership:

(a) Amount beneficially owned:

2,111,661 shares directly held by 3i US Growth Healthcare Fund 2008 L.P., 1,010,175 shares directly held by 3i U.S. Growth Partners L.P., 282,657 shares held directly by 3i Growth Capital (USA) M L.P., 426,812 shares directly held by 3i Growth Capital (USA) E L.P., 63,598 shares directly held by 3i Growth Capital (USA) D L.P. and 63,598 shares directly held by 3i Growth Capital (USA) P L.P. (together, the “3i Funds”). The general partner of each of the 3i Funds is 3i U.S. Growth Corporation. Investment and divestment decisions are made by the board of directors of 3i Corporation, which is the manager of each of the 3i Funds and an indirect wholly owned subsidiary of 3i Group plc, a public company listed on the London Stock Exchange. As a result, 3i Corporation, as manager of each of the 3i Funds, and 3i U.S. Growth Corporation, as general partner of each of the 3i Funds, may be deemed to have voting and dispositive power with respect to the shares of common stock held by the 3i Funds.

(b) Percent of class:

3.3% with respect to 3i Corporation and 3i U.S. Growth Corporation.

(c) Number of shares as to which such person has:

 

  (i) sole power to vote or direct to vote: 0

 

  (ii) shared power to vote or to direct to vote: 3,958,501 with respect to 3i Corporation and 3i U.S. Growth Corporation.

 

  (iii) sole power to dispose or to direct the disposition of: 0

 

  (iv) shared power to dispose or to direct the disposition of: 3,958,501 with respect to 3i Corporation and 3i U.S. Growth Corporation.

Pursuant to Rule 13d-5(b)(1) under the Exchange Act, the Reporting Persons may be deemed as a group to have beneficial ownership of 3,958,501 shares of Common Stock, the aggregate number of shares of Common Stock held by the Reporting Persons, representing approximately 3.3% of the outstanding Common Stock as of date of the filing of this Schedule 13G. All of the percentages calculated in this Schedule 13G are based upon an aggregate of 119,668,196 shares of Common Stock outstanding as of April 26, 2016, as reported on the Issuer’s Quarterly Report on Form 10-Q dated May 3, 2016. Each Reporting Person expressly disclaims beneficial ownership of any shares of Common Stock beneficially owned by each other Reporting Person.


CUSIP No. 74876Y101   13G   Page  6  of 8 Pages

 

Item 5 Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof each of the Reporting Persons has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

 

Item 6 Ownership of More Than Five Percent on Behalf of Another Person:

Not applicable.

 

Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:

Not applicable.

 

Item 8 Identification and Classification of Members of the Group:

Not applicable.

 

Item 9 Notice of Dissolution of Group:

Not applicable.

 

Item 10 Certification:

Not applicable.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: June 16, 2016

 

3i Corporation
By:   /s/ Richard Relyea
  Name: Richard Relyea
  Title: Authorized Signatory

 

3i U.S. Growth Corporation
By:   /s/ Richard Relyea
  Name: Richard Relyea
  Title: Authorized Signatory


Exhibit A

AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13G

The undersigned hereby agree as follows:

(i) Each of them is individually eligible to use the Schedule 13G to which this Exhibit is attached, and such Schedule 13G is filed on behalf of each of them; and

(ii) Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

Date: June 16, 2016

 

3i Corporation
By:   /s/ Richard Relyea
  Name: Richard Relyea
  Title: Authorized Signatory

 

3i U.S. Growth Corporation
By:   /s/ Richard Relyea
  Name: Richard Relyea
  Title: Authorized Signatory